Ramesh Kanuru, MD
Interventional Pain Medicine · Highland, INNPI 1891772281
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Abbott at 27.5% of the total. Reporting peaked in 2019 at $275 and has fallen 67.7% since, to $89 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IN, where the typical reported total is $4,157.
Across 63 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$293
- Johnson & Johnson$145
- Boston Scientific$134
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$76
- Cardiovascular Systems Inc.$66
- Biodelivery Sciences International, Inc.$63
- plus $289 from 9 others
What the payments were for
- Food & beverage$1,065100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $293 |
| Johnson & Johnson(2 entities) | 3 | $145 |
| Boston Scientific | 8 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $76 |
| Cardiovascular Systems Inc. | 1 | $66 |
| Biodelivery Sciences International, Inc. | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Amgen | 3 | $50 |
| Myoscience Inc. | 1 | $48 |
| Nalu Medical, Inc. | 2 | $31 |
| Scilex Pharmaceuticals Inc. | 2 | $28 |
| Assertio Therapeutics, Inc. | 1 | $23 |
| Valinor Pharma, LLC | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $13 |
How this compares
$1,065 in reported general payments places this provider in the 20th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 33 | $4,944 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 201 | $3,056 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 42 | $1,112 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $364 |
| Duloxetine Hcl | 30 | $328 |
| Cyclobenzaprine Hcl | 23 | $270 |
| Tizanidine Hcl | 42 | $249 |
| Celecoxib | 18 | $220 |
| Gabapentin | 19 | $155 |
| Tramadol Hcl | 28 | $114 |
| Sumatriptan Succinate | 13 | $75 |
| Naproxen | 13 | $59 |
| Meloxicam | 13 | $40 |
| Diazepam | 33 | $26 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Highland
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Scott KimGreenwood$18K
- Edward KowlowitzIndianapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.